Status:
COMPLETED
MBCT for People With Parkinson's Disease and Caregivers
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Mount Zion Health Fund
Conditions:
Parkinson Disease
Anxiety
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to explore the feasibility and effectiveness of mindfulness-based cognitive therapy (MBCT) in reducing anxiety and/or depressive symptoms in people with Parkinson's disease (PD) and ca...
Detailed Description
An adapted MBCT intervention will be offered to people with Parkinson's disease (PD) and mild-to-moderate depression and/or anxiety, as well as caregivers of people with PD. Several 8-week long MBCT g...
Eligibility Criteria
Inclusion
- Having a diagnosis of Parkinson's disease (PD) or parkinsonism, established by a neurologist, or being a caregiver of a person with PD or parkinsonism
- Being able and willing to attend 8 weekly 90-minute online group sessions (5-6:30 pm PST)
- Mild-to-moderate anxiety: GAD-7 score ≤ 16
- Mild-to-moderate depression: PHQ-9 score ≤ 18
Exclusion
- Severe anxiety: GAD-7 score \> 16
- Moderately severe-to-severe depression: PHQ-9 score \> 18
- Cognitive impairment: Montreal Cognitive Assessment (MoCA) score \< 24
- Heavy alcohol or drug use
- Severe psychosis
- Active suicidal or homicidal ideation
- For people with PD: severe motor fluctuations (less than 2 hours "on" time per day)
- Pattern of engagement with health care that indicates low likelihood of completing an 8-week intervention.
Key Trial Info
Start Date :
November 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 11 2021
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT04469049
Start Date
November 11 2020
End Date
June 11 2021
Last Update
October 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143